Clinical Trials Logo

Cervical Ripening clinical trials

View clinical trials related to Cervical Ripening.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT05096104 Completed - Cervical Ripening Clinical Trials

Patient Satisfaction During Artificial Induction of Labor by Cervical Ripening

CERVICAL
Start date: August 6, 2021
Phase:
Study type: Observational

20% of deliveries take place following an artificial induction of labor. The latter sometimes requires prior cervical ripening, of which the two most widely used methods in France are oral misoprostol and the balloon catheter, left to the discretion of clinicians. The objective of this study is to observe which cervical maturation method patients choose when an artificial induction of labor with an unfavorable cervical status must be carried out, and to observe the patient's criteria as to the choice made, as well as their experience and their satisfaction with artificial induction of labor, in order to improve our clinical practices, the experience of childbirth, and promote patient autonomy.

NCT ID: NCT04773314 Completed - Pregnancy Clinical Trials

General Drug Use-results Survey on PROPESS Vaginal Inserts in Treatment for Initiation of Cervical Ripening in Patients at Term (From 37 Completed Weeks of Gestation)

Start date: February 28, 2021
Phase:
Study type: Observational

To confirm and consider the occurrence of important identified risks described in the Japanese Pharmaceutical Risk Management Plan (J-RMP) under conditions used in routine medical practice. The safety specification include: uterine hypercontractions and associated foetal distress, uterine rupture, cervical laceration, amniotic fluid embolism, and foetal distress.

NCT ID: NCT04687436 Completed - Cervical Ripening Clinical Trials

Foley Catheter Versus Double-balloon Catheter for Cervical Ripening

Start date: July 1, 2020
Phase:
Study type: Observational

The objective of this study is to compare pregnancy results which were used foley catheter or double-balloon catheter for cervical ripening among high-risk pregnant women.

NCT ID: NCT03928600 Completed - Cervical Ripening Clinical Trials

Labor Induction With a Combined Method (Pharmacologic and Mechanical): Randomized Controlled Trial

Start date: February 1, 2018
Phase: N/A
Study type: Interventional

Labor induction is a common pregnancy procedure worldwide. Both mechanical and pharmacologic agents are used for induction of labor. These agents reduce the incidence of cesarean delivery in women undergoing induction. Opposite to old studies of cervical ripening, some recent studies have shown promise in reducing labor time and risk of cesarean delivery with combination methods. The effectiveness of this procedure is of major clinical importance and has a large impact in our quotidian practice. The objective is to compare the effectiveness of a combined new method to current guidelines of our department

NCT ID: NCT03744364 Completed - Pregnancy Clinical Trials

Low-dose Vaginal Misoprostol Versus Vaginal Dinoprostone Insert for Induction of Labor

MADUTER
Start date: June 1, 2014
Phase: Phase 4
Study type: Interventional

Purpose: To compare the efficacy and safety of low-dose protocol of vaginal misoprostol and vaginal dinoprostone insert for induction of labor in women with post-term pregnancies. Methods: The investigators designed a prospective, randomized, open-labeled, blinded for the end-point evaluators trial including women of at least 41 weeks of gestational age with uncomplicated singleton pregnancies and Bishop score lower than 6. Participants were randomized into dinoprostone or misoprostol groups in a 1:1 ratio. Baseline maternal data and perinatal outcomes were recorded for statistical analysis. Successful vaginal delivery within 24 hours was the primary outcome variable.

NCT ID: NCT03138252 Completed - Induction of Labor Clinical Trials

Study of the Effectiveness of Cervical Ripening Balloon With and Without Oxytocin

Start date: November 2014
Phase: Phase 3
Study type: Interventional

Study Purpose: The purpose of this study is to determine the optimal method for induction of labor in multiparous women who present with an unfavorable cervix. Hypothesis: Our hypothesis is that using oxytocin while the cervical ripening balloon is in place will result in more rapid labor courses, without increasing morbidity or increasing the need for operative delivery.

NCT ID: NCT03111316 Completed - Induction of Labor Clinical Trials

Foley Catheter Compared to the Foley Catheter Alone for Cervical Ripening

Start date: April 9, 2017
Phase: N/A
Study type: Interventional

In term women presenting for labor induction, combined use of the controlled release dinoprostone vaginal insert and Foley catheter for cervical ripening will decrease the median time from induction to vaginal delivery by at least four hours compared to the Foley catheter alone.

NCT ID: NCT03067727 Completed - Cervical Ripening Clinical Trials

A Randomised Trial Investigating the Efficacy and Safety of a Vaginal Insert in Pregnant Women at Term

Start date: April 3, 2017
Phase: Phase 3
Study type: Interventional

To demonstrate the efficacy of dinoprostone vaginal insert (DVI) for cervical ripening success (either bishop score (BS) ≥7 or vaginal delivery) within 12 hours of vaginal insert administration

NCT ID: NCT03067597 Completed - Cervical Ripening Clinical Trials

An Open-label Trial Investigating the Efficacy and Safety of a Vaginal Insert in Pregnant Women at Term

Start date: February 22, 2017
Phase: Phase 3
Study type: Interventional

To demonstrate the efficacy of controlled-release dinoprostone vaginal insert (DVI) for cervical ripening success (either Bishop Score (BS) ≥7 or vaginal delivery) within 12 hours of vaginal insert administration.

NCT ID: NCT02732522 Completed - Cervical Ripening Clinical Trials

Comparison Between Vaginal and Sublingual Misoprostol 50 µg for Cervical Ripening Prior to Induction of Labor

CMVS
Start date: October 2014
Phase: Phase 4
Study type: Interventional

To analyze whether there is a statistically significant difference in the modifications present in the uterine cervix 6 hours after administration of misoprostol 50 µg through vaginal versus sublingual routes.